These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 15288291

  • 1. European collaboration in trials of new agents for children with cancer.
    Ablett S, Doz F, Morland B, Vassal G, New Agents Group of the United Kingdom Children's Cancer Study Group (UKCCSG), Pharmacology Group of the French Society of Paediatric Oncology (SFOP).
    Eur J Cancer; 2004 Aug; 40(12):1886-92. PubMed ID: 15288291
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Can Canada sustain paediatric phase I trials? A national survey of cancer relapse in children.
    Lau L, Baruchel S, Council of Canadian Paediatric Haematology/Oncology Directors.
    Can J Clin Pharmacol; 2005 Aug; 12(3):e222-8. PubMed ID: 16278494
    [Abstract] [Full Text] [Related]

  • 4. Developing new agents for the treatment of childhood cancer.
    Kurmasheva R, Morton C, Houghton PJ.
    Curr Opin Investig Drugs; 2005 Dec; 6(12):1215-27. PubMed ID: 16372407
    [Abstract] [Full Text] [Related]

  • 5. [Present strategy for new drug development in the USA].
    Shimada Y.
    Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():315-24. PubMed ID: 7986110
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. From laboratory to Phase I/II cancer trials with recombinant biotherapeutics.
    Tolner B, Smith L, Hillyer T, Bhatia J, Beckett P, Robson L, Sharma SK, Griffin N, Vervecken W, Contreras R, Pedley RB, Begent RH, Chester KA.
    Eur J Cancer; 2007 Nov; 43(17):2515-22. PubMed ID: 17933516
    [Abstract] [Full Text] [Related]

  • 8. Lessons learned from independent central review.
    Ford R, Schwartz L, Dancey J, Dodd LE, Eisenhauer EA, Gwyther S, Rubinstein L, Sargent D, Shankar L, Therasse P, Verweij J.
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Recent proposals for early stage clinical trials of cancer].
    Ohashi Y.
    Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():292-4. PubMed ID: 7986106
    [Abstract] [Full Text] [Related]

  • 11. The role of the 'innovative therapies for children with cancer' (ITCC) European consortium.
    Zwaan CM, Kearns P, Caron H, Verschuur A, Riccardi R, Boos J, Doz F, Geoerger B, Morland B, Vassal G, 'innovative therapies for children with cancer' European consortium.
    Cancer Treat Rev; 2010 Jun; 36(4):328-34. PubMed ID: 20231057
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Principle and practice of clinical phase III studies].
    Morant R.
    Onkologie; 2008 Jun; 31 Suppl 2():53-7. PubMed ID: 18487870
    [Abstract] [Full Text] [Related]

  • 15. Tissue collection for correlative studies in childhood cancer clinical trials: ethical considerations and special imperatives.
    Anderson BD, Adamson PC, Weiner SL, McCabe MS, Smith MA.
    J Clin Oncol; 2004 Dec 01; 22(23):4846-50. PubMed ID: 15570088
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. KS Biomedix licenses TransMID brain cancer product to Nycomed in European collaboration.
    Expert Rev Anticancer Ther; 2002 Oct 01; 2(5):481. PubMed ID: 12382509
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [The revision of Guidelines for Clinical Evaluation Methods of Anti-Cancer Drugs in Japan].
    Andoh M, Fujiwara Y, Shimada Y.
    Gan To Kagaku Ryoho; 2006 Jul 01; 33(7):1015-9. PubMed ID: 16878363
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.